drugset / Trial / NCT02424955

Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation

NCT02424955

Completed 11 enrolled Stanford University
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to prospectively analyze the value of 3D ultrasound perfusion imaging for treatment planning, the prediction of therapy success, and to monitor the treatment response in patients with a primary or metastatic liver tumor undergoing radiation treatment.

Timeline

Start
2014-11-18
Primary completion
2022-06-30
Completion
2022-06-30

Drugs

EvaluationDrugModalityDoseRoute
Background Definity Diagnostic / imaging agent